Cantor Fitzgerald Maintains a Buy Rating on Crinetics Pharmaceuticals (CRNX)

Oct 9, 2025 - 05:00

1

Cantor Fitzgerald Maintains a Buy Rating on Crinetics Pharmaceuticals (CRNX)

Related Posts

Coty Divests Stake in SKKN by Kim

Coty Divests Stake in SKKN by Kim

Mar 21, 2025 0

Airlines issue travel waivers due to London's Heathrow Airport shutdown

Airlines issue travel waivers due to London's Heathrow ...

Mar 21, 2025 0

Businesses may have to pass high beef prices on to consumers

Businesses may have to pass high beef prices on to cons...

Mar 21, 2025 0

JPMorgan rebrands diversity program

JPMorgan rebrands diversity program

Mar 21, 2025 4

ZipRecruiter SVP Bartolome Lora sells $12,861 in shares

ZipRecruiter SVP Bartolome Lora sells $12,861 in shares

Mar 21, 2025 1

The five keys to unlock homeownership for emerging buyers

The five keys to unlock homeownership for emerging buyers

Mar 21, 2025 0